Arcutis Biotherapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022
Filed with the SEC on Sep 15, 2023 and accepted by EDGAR at Sep 15, 2023, 16:07 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001787306-23-000103. Last ingested by Listed: Nov 4, 2026, 20:19 ET. Listed shows no prices and gives no investment advice.